BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 22417299)

  • 21. MicroRNAs as Guardians of the Prostate: Those Who Stand before Cancer. What Do We Really Know about the Role of microRNAs in Prostate Biology?
    Andl T; Ganapathy K; Bossan A; Chakrabarti R
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32645914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
    Duarte FV; Palmeira CM; Rolo AP
    Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate cancer small non-coding RNA transcriptome in Arabs.
    Shan J; Al-Rumaihi K; Chouchane K; Al-Bozom I; Rabah D; Farhat K; Chouchane L
    J Transl Med; 2017 Dec; 15(1):260. PubMed ID: 29268752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNAs and the Response of Prostate Cancer to Anti-Cancer Drugs.
    Pennati M; Folini M; Gandellini P; Zaffaroni N
    Curr Drug Targets; 2016; 17(3):257-65. PubMed ID: 25777275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The microRNA signatures: aberrantly expressed miRNAs in prostate cancer.
    Sharma N; Baruah MM
    Clin Transl Oncol; 2019 Feb; 21(2):126-144. PubMed ID: 29951892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exosome-derived microRNAs contribute to prostate cancer chemoresistance.
    Li J; Yang X; Guan H; Mizokami A; Keller ET; Xu X; Liu X; Tan J; Hu L; Lu Y; Zhang J
    Int J Oncol; 2016 Aug; 49(2):838-46. PubMed ID: 27278879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-214-5p inhibits human prostate cancer proliferation and migration through regulating CRMP5.
    Zheng C; Guo K; Chen B; Wen Y; Xu Y
    Cancer Biomark; 2019; 26(2):193-202. PubMed ID: 31403941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA and Cancer: Tiny Molecules with Major Implications.
    Vandenboom Ii TG; Li Y; Philip PA; Sarkar FH
    Curr Genomics; 2008 Apr; 9(2):97-109. PubMed ID: 19440450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Application of microRNAs to Cancer Therapy].
    Iguchi H; Ochiya T
    Gan To Kagaku Ryoho; 2010 Mar; 37(3):389-95. PubMed ID: 20332672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-143 and -145 in colon cancer.
    Akao Y; Nakagawa Y; Naoe T
    DNA Cell Biol; 2007 May; 26(5):311-20. PubMed ID: 17504027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNAs and prostate cancer.
    Shi XB; Tepper CG; White RW
    J Cell Mol Med; 2008; 12(5A):1456-65. PubMed ID: 18624768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deep sequencing of small RNA libraries from human prostate epithelial and stromal cells reveal distinct pattern of microRNAs primarily predicted to target growth factors.
    Singh S; Zheng Y; Jagadeeswaran G; Ebron JS; Sikand K; Gupta S; Sunker R; Shukla GC
    Cancer Lett; 2016 Feb; 371(2):262-73. PubMed ID: 26655274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic Identification of MicroRNAs That Impact on Proliferation of Prostate Cancer Cells and Display Changed Expression in Tumor Tissue.
    Aakula A; Kohonen P; Leivonen SK; Mäkelä R; Hintsanen P; Mpindi JP; Martens-Uzunova E; Aittokallio T; Jenster G; Perälä M; Kallioniemi O; Östling P
    Eur Urol; 2016 Jun; 69(6):1120-8. PubMed ID: 26489476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miRNAs and cancer: New research developments and potential clinical applications.
    Erson AE; Petty EM
    Cancer Biol Ther; 2009 Dec; 8(24):2317-22. PubMed ID: 20168083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNAs and their potential for translation in prostate cancer.
    DeVere White RW; Vinall RL; Tepper CG; Shi XB
    Urol Oncol; 2009; 27(3):307-11. PubMed ID: 19414119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiRNA targets of prostate cancer.
    Deng JH; Deng Q; Kuo CH; Delaney SW; Ying SY
    Methods Mol Biol; 2013; 936():357-69. PubMed ID: 23007521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The regulation of HAS3 by miR-10b and miR-29a in neuroendocrine transdifferentiated LNCaP prostate cancer cells.
    Czyrnik ED; Wiesehöfer M; Dankert JT; Wennemuth G
    Biochem Biophys Res Commun; 2020 Mar; 523(3):713-718. PubMed ID: 31948751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.
    Fuse M; Kojima S; Enokida H; Chiyomaru T; Yoshino H; Nohata N; Kinoshita T; Sakamoto S; Naya Y; Nakagawa M; Ichikawa T; Seki N
    J Hum Genet; 2012 Nov; 57(11):691-9. PubMed ID: 22854542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.
    Xiaoli Z; Yawei W; Lianna L; Haifeng L; Hui Z
    Med Sci Monit; 2015 Dec; 21():3748-59. PubMed ID: 26628405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNAs in prostate cancer: Functional role as biomarkers.
    Kanwal R; Plaga AR; Liu X; Shukla GC; Gupta S
    Cancer Lett; 2017 Oct; 407():9-20. PubMed ID: 28823964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.